Trials / Unknown
UnknownNCT03507595
Evaluation of the Metastasis and Recurrence of Prostate Cancer
Evaluation of the Metastasis and Recurrence of Prostate Cancer With 18F-PSMA PET/CT
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Academic / Other
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study aims to use the new molecular probe 18F-PSMA for the diagnosis,staging ,recurrence monitoring and evaluation of the prostate cancer.By compared with the conventional imaging methods (whole body bone scintigraphy and MRI) and molecular imaging methods (11C-choline PET/CT),we hope to find the advantages of 18F-PSMA PET/CT in the diagnosis and metastases of prostate cancer, and lay the foundation for the further clinical transformation.
Detailed description
This study aims to use the new molecular probe 18F-PSMA for the diagnosis,staging ,recurrence monitoring and evaluation of the prostate cancer.By compared with the conventional imaging methods (whole body bone scintigraphy and MRI) and molecular imaging methods (11C-choline PET/CT),we hope to find the advantages of 18F-PSMA PET/CT in the diagnosis and metastases of prostate cancer, and lay the foundation for the further clinical transformation.And make some comparison with those 3 methods.
Conditions
Timeline
- Start date
- 2017-09-01
- Primary completion
- 2019-10-31
- Completion
- 2019-12-31
- First posted
- 2018-04-25
- Last updated
- 2018-04-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03507595. Inclusion in this directory is not an endorsement.